World of DTC Marketing

AUGUST 12, 2022

The more excess profit comes from the next 100 or 200 brand-name drugs. Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData. It also raises healthcare costs for public and private insurers alike.

Drugs 255

Drugs Research Development Regulation 255

Pharmaceutical Technology

JULY 14, 2022

This analysis is based on the GlobalData Pharma Intelligence Center’s Deals database and PharmSource reports. In the same realm, Moderna received a positive bump when the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved Spikevax’s use in children aged six to 11. Covid-19 vaccines stay in the spotlight.

Manufacturing 130

Manufacturing Drugs Vaccination Vaccine 130

Pharmaceutical Technology

JULY 14, 2022

This, believes Kahn, is where the role of healthcare systems is critical. Healthcare systems should provide an attractive environment for these innovators to launch their orphan drug assets, while innovators should focus on cost optimisation to ensure patient access is not jeopardised by profitability concerns.”.

Drugs 147

Drugs Medicine Marketing Development 147

XTalks

MAY 2, 2024

Among these are Madrigal Pharmaceuticals’ resmetirom (branded Rezdiffra) , which secured FDA approval in March for the treatment of nonalcoholic steatohepatitis (NASH) and sotatercept (commercial name Winrevair) for pulmonary hypertension (PAH). Since January, the FDA has already signed off on more than a dozen novel drugs. At the J.P.

Drugs 52

Drugs FDA Approval Sales Vaccination 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

The company told GlobalData PharmSource: “The biosimilar facilities in Austria and Slovenia would continue to manufacture biosimilars for Sandoz under a contractual agreement with Novartis. Sandoz owns nine sites that are based in the US, Europe and India; most of the brand's sites offer commercial solid dose capabilities.

Manufacturing 162

Manufacturing Drugs Branding Sales 162

Pharmaceutical Technology

NOVEMBER 15, 2022

In May 2022, the CDC held a Health Alert Network (HAN) Health Advisory to update healthcare providers, public health departments, and the public on the potential for the recurrence of Covid-19 or “Covid-19 rebound.” These symptoms tend to remain mild and resolve themselves without the need for additional treatment. billion dollar contract.

Vaccination 162

Vaccination Vaccine Clinical Trials Clinical Trials 162

pharmaphorum

NOVEMBER 19, 2021

In the second quarter alone the vaccine, branded as Comirnaty, raked in $7.8 The market is becoming tougher to enter as we control the outbreak and the main vaccines become more dominant,” says Mike Breen, director of infectious diseases and ophthalmology at GlobalData. Meanwhile, China and Russia have rolled out state-owned vaccines.

Sales 136

Sales Vaccination Vaccine Marketing 136

pharmaphorum

SEPTEMBER 16, 2022

The EMA’s human medicines committee – the CHMP – has recommended approval of a single dose of the antibody, given to prevent lower respiratory tract infections caused by RSV, under the Beyfortus brand name. Both vaccines are also being tested in older adults.

Antibody 59

Antibody Vaccination Vaccine Marketing 59

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. Barriers to access post-approval After the FDA approves a branded or generic drug, the application holder makes the ultimate decision as to when to market the product.

Generic Drugs 246

Generic Drugs Branding Drugs Production 246

Pharmaceutical Technology

DECEMBER 9, 2022

This size alone brings significant benefits to its citizens, with Brazil having a publicly funded and government-run healthcare system offering free and universal access to healthcare for the entire population. Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures.

Marketing 246

Marketing Sales Production Medicine 246

Pharmaceutical Technology

DECEMBER 4, 2022

Broadly speaking, price is the determining factor on the US healthcare market, says Jakub Hlávka, PhD, research assistant professor of health policy and management at the University of South California, Los Angeles. Watanabe says there are going to be some attempts by an innovator brand to defend its space. By GlobalData.

Marketing 262

Marketing Pharmacy Production Branding 262

Pharmaceutical Technology

FEBRUARY 6, 2023

According to GlobalData, there are 25 marketed drugs for IPF available in North America. GlobalData is the parent company of Pharmaceutical Technology. According to GlobalData, 29 drugs are currently marketed for managing the complications of PSC, but none can reverse liver damage associated with PSC.

Marketing 147

Marketing Clinical Trials Clinical Trials Trials 147

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. By GlobalData. United Kingdom. United States. Afghanistan.

Doctors 242

Doctors Doctor Drugs Sales 242

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. Sea change Findings from GlobalData point to rising interest in trial decentralisation across the pharmaceutical industry.

Clinical Trials 147

Clinical Trials Clinical Trials Trials Research 147

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. Sea change Findings from GlobalData point to rising interest in trial decentralisation across the pharmaceutical industry.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130